골수성질환에서 단독 염색체 이상으로 19번 삼염색체를 보인 2예
Two Cases of Trisomy 19 as a Sole Chromosomal Abnormality in Myeloid Disorders
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Trisomy 19 is frequently encountered in cases of chronic myeloid leukemia (CML) as a secondary abnormality: however, trisomy 19 rarely occurs as a sole chromosomal abnormality and, to date, it has only been reported in 48 hematopoietic malignancies, 1 case of adenocarcinoma and 1 case of astrocytic tumor. Here, we report two additional cases of trisomy 19 as a sole karyotypic aberration in myeloid malignancies. One of these cases involved a 6-month-old male who was diagnosed with acute myeloid leukemia minimally differentiated. His karyotype was 47,XY,+19[20]. He expired 5 days after diagnosis. Another case occurred in an 80-yr-old female who had refractory anemia with excess blasts. Her karyotype was 47,XX,+19[16]/46,XX[4]. Four months later, her peripheral blood smears suggested that the disease had progressed, but she refused further evaluation. Based on a review of the existing literature and the results of this report, trisomy 19 not only as a secondary abnormality but also as a sole karyotypic aberration is strongly associated with myeloid disorder; however, it is not preferentially found in specific FAB subgroups of myelodysplasic syndrome or acute myeloid leukemia. (Korean J Lab Med 2008;28:174-8)
Abstract
Trisomy 19 is frequently encountered in cases of chronic myeloid leukemia (CML) as a secondary abnormality: however, trisomy 19 rarely occurs as a sole chromosomal abnormality and, to date, it has only been reported in 48 hematopoietic malignancies, 1 case of adenocarcinoma and 1 case of astrocytic tumor. Here, we report two additional cases of trisomy 19 as a sole karyotypic aberration in myeloid malignancies. One of these cases involved a 6-month-old male who was diagnosed with acute myeloid leukemia minimally differentiated. His karyotype was 47,XY,+19[20]. He expired 5 days after diagnosis. Another case occurred in an 80-yr-old female who had refractory anemia with excess blasts. Her karyotype was 47,XX,+19[16]/46,XX[4]. Four months later, her peripheral blood smears suggested that the disease had progressed, but she refused further evaluation. Based on a review of the existing literature and the results of this report, trisomy 19 not only as a secondary abnormality but also as a sole karyotypic aberration is strongly associated with myeloid disorder; however, it is not preferentially found in specific FAB subgroups of myelodysplasic syndrome or acute myeloid leukemia. (Korean J Lab Med 2008;28:174-8)
참고문헌 (11)
- "Primary, single, autosomal trisomies associated with haematological disorders. United Kingdom Cancer Cytogenetics Group (UKCCG). Leuk Res 1992;16:841-51", ~ (1992)
- Mitelman F, "Mitelman database of chromosome aberrations in cancer. http:", Chromosomes, pp.Mitelman (Updated on Aug 2007)[DOI]
- Johansson B, "Trisomy 19 as the sole chromosomal anomaly in hematologic neoplasms", Cancer Genet Cytogenet, 74, pp.62~65 (1994)
- Heim S, "Nonrandom chromosome abnormalities in cancer-an overview in; Cancer cytogenetics", pp.19~32 (1995), Wiley-Liss Inc.
- Diez-Martin JL, "Possible cytogenetic distinction between lymphoid and myeloid blast crisis in chronic granulocytic leukemia", Am J Hematol, 27, pp.194~203 (1988)
- Nimer SD, "Chromosome 19 abnormalities are commonly seen in AML, M7", Blood, 100, pp.3838~ (2002)
- Daskalakis M, "Trisomy 19 as the sole chromosome abnormality in proliferative chronic myelomonocytic leukemia", Leuk Res, 30, pp.1043~1047 (2006)
- Hartley SE, "Acute leukemia and the same chromosome abnormality in monozygotic twins", Hum Genet, 58, pp.408~410 (1981)
- Babic I, "Prenatal diagnosis of complete trisomy 19q", Prenat Diagn, 27, pp.644~647 (2007)
- Langer F, "Up-regulation of DNA methyltransferase DNMT1, 3A, and 3B in myelodysplastic syndrome", Leuk Res, 29, pp.325~329 (2005)
- Daskalakis M, "Demethylation of a hypermethylated P15", INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2’-deoxycytidine(decitabine) treatment, 2002, pp.100, 2957~2964